News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Naseem Amarshi, PharmD

Articles by Naseem Amarshi, PharmD

Evaluation of Angiotensin-Converting Enzyme Inhibitor Use in Patients With Type 2 Diabetes in a State Managed Care Plan

ByErin M. Timpe, PharmD,Naseem Amarshi, PharmD,Pamala J. Reed, DrPH

February 1st 2004

Latest Updated Articles

Evaluation of Angiotensin-Converting Enzyme Inhibitor Use in Patients With Type 2 Diabetes in a State Managed Care Plan
Published: February 1st 2004 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

How Do GLP-1 Agonists Fit Into Stroke Care?

Exploring Identity, Appearance Experiences Among Patients With Alopecia

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text